Medicare Prescription Drug, Improvement, and Modernization Act of 2003
E544646
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 is a major U.S. federal law that overhauled Medicare by adding outpatient prescription drug coverage and expanding private plan options for beneficiaries.
All labels observed (4)
How this entity was disambiguated
This entity first appeared as the object of triple T5765674 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Context triple: [Medicare Part D, createdBy, Medicare Prescription Drug, Improvement, and Modernization Act of 2003]
-
A.
Food and Drug Administration Amendments Act of 2007
The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
-
B.
Prescription Drug User Fee Act of 1992
The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
-
C.
Drug Price Competition and Patent Term Restoration Act of 1984
The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.
-
D.
Healthcare Research and Quality Act of 1999
The Healthcare Research and Quality Act of 1999 is a U.S. federal law that reauthorized and strengthened the nation’s health services research infrastructure, establishing a focused mission to improve the quality, safety, efficiency, and effectiveness of healthcare.
-
E.
Deficit Reduction Act of 2005
The Deficit Reduction Act of 2005 is a U.S. federal law aimed at cutting government spending and reducing the federal budget deficit, notably affecting programs such as Medicare and Medicaid.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Target entity description: The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 is a major U.S. federal law that overhauled Medicare by adding outpatient prescription drug coverage and expanding private plan options for beneficiaries.
-
A.
Food and Drug Administration Amendments Act of 2007
The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
-
B.
Prescription Drug User Fee Act of 1992
The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
-
C.
Drug Price Competition and Patent Term Restoration Act of 1984
The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.
-
D.
Healthcare Research and Quality Act of 1999
The Healthcare Research and Quality Act of 1999 is a U.S. federal law that reauthorized and strengthened the nation’s health services research infrastructure, establishing a focused mission to improve the quality, safety, efficiency, and effectiveness of healthcare.
-
E.
Deficit Reduction Act of 2005
The Deficit Reduction Act of 2005 is a U.S. federal law aimed at cutting government spending and reducing the federal budget deficit, notably affecting programs such as Medicare and Medicaid.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
Medicare legislation
ⓘ
United States federal statute ⓘ |
| affects |
Medicare beneficiaries
ⓘ
pharmaceutical industry ⓘ private health plans ⓘ |
| aimedTo |
increase role of private plans in Medicare
ⓘ
modernize Medicare benefits ⓘ |
| alsoKnownAs | Medicare Prescription Drug Benefit law NERFINISHED ⓘ |
| billNumberHouse | H.R.1 (108th Congress) NERFINISHED ⓘ |
| codifiedIn | Title 42 of the United States Code NERFINISHED ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| createdProgram |
Health Savings Account
NERFINISHED
ⓘ
Medicare Advantage NERFINISHED ⓘ Medicare Part D NERFINISHED ⓘ |
| dateSigned | 2003-12-08 ⓘ |
| debatedIssue |
extent of subsidies to private insurers and drug plans
ⓘ
lack of federal negotiation of drug prices ⓘ long-term fiscal impact on Medicare ⓘ |
| enactedBy | 108th United States Congress NERFINISHED ⓘ |
| established | standard Medicare Part D benefit design including coverage gap ⓘ |
| expanded |
Medicare managed care into Medicare Advantage (Part C)
ⓘ
private plan options for Medicare beneficiaries ⓘ |
| implementedProgramStartDate | Medicare Part D 2006-01-01 ⓘ |
| introducedConcept | Medicare Part D coverage gap (donut hole) NERFINISHED ⓘ |
| introducedInChamber | United States House of Representatives NERFINISHED ⓘ |
| legislativeStatus | in force ⓘ |
| majorProvision |
creation of Health Savings Accounts
ⓘ
means-tested premiums for higher-income beneficiaries ⓘ outpatient prescription drug coverage for Medicare beneficiaries ⓘ subsidies for employer-sponsored retiree drug coverage ⓘ temporary Medicare prescription drug discount card program ⓘ |
| policyArea |
health care
ⓘ
social insurance ⓘ |
| politicalContext | George W. Bush administration domestic policy ⓘ |
| presidentAtSigning | George W. Bush NERFINISHED ⓘ |
| primarySubject |
Medicare
NERFINISHED
ⓘ
prescription drug coverage ⓘ |
| prohibits | direct negotiation by the federal government over Part D drug prices ⓘ |
| provides |
federal subsidies to private prescription drug plans
ⓘ
low-income subsidies for Medicare Part D enrollees ⓘ |
| publicLawNumber | Public Law 108-173 NERFINISHED ⓘ |
| regulates |
Medicare Advantage prescription drug plans (MA-PDs)
NERFINISHED
ⓘ
Medicare prescription drug plans (PDPs) NERFINISHED ⓘ |
| shortName |
MMA
NERFINISHED
ⓘ
Medicare Modernization Act NERFINISHED ⓘ |
| signedBy | George W. Bush ⓘ |
| sponsorChamber | Republican-controlled Congress ⓘ |
| titleOfProgramCreated | Medicare Part D prescription drug benefit NERFINISHED ⓘ |
| yearEnacted | 2003 ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Description of subject: The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 is a major U.S. federal law that overhauled Medicare by adding outpatient prescription drug coverage and expanding private plan options for beneficiaries.
Referenced by (4)
Full triples — surface form annotated when it differs from this entity's canonical label.